Staphylococcus aureus vaccines based on bacterins surrounded by slime, surface polysaccharides coupled to protein carriers and polysaccharides embedded in liposomes administered together with non-biofilm bacterins confer protection against mastitis. However, it remains unknown whether protective antibodies are directed to slime-associated known exopolysaccharides and could be produced in the absence of bacterin immunizations. Here, a sheep mastitis vaccination study was carried out using bacterins, crude bacterial extracts or a purified exopolysaccharide from biofilm bacteria delivered in different vehicles. This polysaccharide reacted specifically with antibodies to poly-N-acetyl-beta-1,6-glucosamine (PNAG) and not with antibodies to other capsular antigens or bacterial components. Following intra-mammary challenge with biofilm-producing bacteria, antibody production against the polysaccharide, milk bacterial counts and mastitis lesions were determined. Bacterins from strong biofilm-producing bacteria triggered the highest production of antibodies to PNAG and conferred the highest protection against infection and mastitis, compared with weak biofilm-producing bacteria and non-cellular inocula. Thus, bacterins from strong biofilm bacteria, rather than purified polysaccharide, are proposed as a cost-efficient vaccination against S. aureus ruminant mastitis.
Staphylococcus aureus vaccines based on bacterins surroun class="Disease">nded by slime, surface polysaccharides coupled to protein carriers andpolysaccharides embedded in liposomes administered together with non-biofilm bacterins confer protection against mastitis. However, it remains unknown whether protective antibodies are directed to slime-associated known exopolysaccharides and could be produced in the absence of bacterin immunizations. Here, a sheep mastitis vaccination study was carried out using bacterins, crude bacterial extracts or a purified exopolysaccharide from biofilm bacteria delivered in different vehicles. This polysaccharide reacted specifically with antibodies to poly-N-acetyl-beta-1,6-glucosamine (PNAG) and not with antibodies to other capsular antigens or bacterial components. Following intra-mammary challenge with biofilm-producing bacteria, antibody production against the polysaccharide, milk bacterial counts andmastitis lesions were determined. Bacterins from strong biofilm-producing bacteria triggered the highest production of antibodies to PNAG and conferred the highest protection against infection and mastitis, compared with weak biofilm-producing bacteria and non-cellular inocula. Thus, bacterins from strong biofilm bacteria, rather than purified polysaccharide, are proposed as a cost-efficient vaccination against S. aureus ruminant mastitis.
Authors: D McKenney; K L Pouliot; Y Wang; V Murthy; M Ulrich; G Döring; J C Lee; D A Goldmann; G B Pier Journal: Science Date: 1999-05-28 Impact factor: 47.728
Authors: Tomás Maira-Litrán; Andrea Kropec; C Abeygunawardana; Joseph Joyce; George Mark; Donald A Goldmann; Gerald B Pier Journal: Infect Immun Date: 2002-08 Impact factor: 3.441
Authors: Anastasia I Spiliopoulou; Maria I Krevvata; Fevronia Kolonitsiou; Llinos G Harris; Thomas S Wilkinson; Angharad P Davies; Georgios O Dimitracopoulos; Nikos K Karamanos; Dietrich Mack; Evangelos D Anastassiou Journal: BMC Microbiol Date: 2012-05-17 Impact factor: 3.605
Authors: Janette M Harro; Brian M Peters; Graeme A O'May; Nathan Archer; Patrick Kerns; Ranjani Prabhakara; Mark E Shirtliff Journal: FEMS Immunol Med Microbiol Date: 2010-05-29